Takeda Denial Of Nycomed Pursuit Countered By Logic Of Move
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical is attempting to squelch rumors it is attempting to buy Swiss drug maker Nycomed for about $12 billion, but the squelching effort is not being taken seriously